Q5® Site-Directed Mutagenesis Kit#E0554

Catalog # Size Price (£)
E0554S 10 reactions £167.00
Description

The Q5® Site-Directed Mutagenesis Kit enables rapid, site-specific mutagenesis of double-stranded plasmid DNA in less than 2 hours (Figure 1). The kit utilizes the robust Q5 Hot Start High-Fidelity DNA Polymerase along with custom mutagenic primers to create insertions, deletions and substitutions in a wide variety of plasmids. After PCR, the amplified material is added directly to a unique Kinase-Ligase-DpnI (KLD) enzyme mix for rapid (5 minutes), room temperature circularization and template removal (Figure 2). Transformation into high-efficiency NEB 5-alpha Competent E. coli, provided with the kit, ensures robust results with plasmids up to at least 20 kb in length.

Figure 1: Site-specific mutagenesis proceeds in less than 2 hours.Figure 1: Site-specific mutagenesis proceeds in less than 2 hours.
The use of a master mix, a unique multi-enzyme KLD enzyme mix, and a fast polymerase ensures that, for most plasmids, the mutagenesis reaction is complete in less than two hours.    
Figure 2: Q5 Site-Directed Mutagenesis Kit Overview. Figure 2: Q5 Site-Directed Mutagenesis Kit Overview.
This kit is designed for rapid and efficient incorporation of insertions, deletions and substitutions into doublestranded plasmid DNA. The first step is an exponential amplification using standard primers and a master mix fomulation of Q5 Hot Start High-Fidelity DNA Polymerase. The second step involves incubation with a unique enzyme mix containing a kinase, a ligase and DpnI. Together, these enzymes allow for rapid circularization of the PCR product and removal of the template DNA. The last step is a high-efficiency transformation into chemicallycompetent cells (provided).Figure 3: Primer Design for the Q5 Site-Directed Mutagenesis KitFigure 3: Primer Design for the Q5 Site-Directed Mutagenesis Kit
Substitutions, deletions and insertions are incorporated into plasmid DNA through the use of specifically designed forward (black) and reverse (red) primers. Unlike kits that rely on linear amplification, primers designed for the Q5 Site-Directed Mutagenesis Kit should not overlap to ensure that the benefits of
exponential amplification are realized.
A) Substitutions are created by incorporating the desired nucleotide change(s) (denoted by *) in the center of the forward primer, including at least 10 complementary nucleotides on the 3´side of the mutation(s). The reverse primer is designed so that the 5´ ends of the two primers anneal back-to- back. B) Deletions are engineered by designing standard, non-mutagenic forward and reverse primers that flank the region to be deleted. C) Insertions less than or equal to 6 nucleotides are incorporated into the 5´ end of the forward primer while the reverse primer anneals back-to-back with the 5´ end of the complementary region of the forward primer. D) Larger insertions can be created by incorporating half of the desired insertion into the 5´ ends of both primers. The maximum size of the insertion is largely dictated by oligonucleotide synthesis limitations. Figure 4: NEB's Q5 SDM Kit delivers higher transformation efficiency than Agilent's QuikChange® SDM Kit
Q5 GraphResults from a substitution reaction (4 nt) using the back-to-back Control SDM Primer Mix and Control SDM Plasmid (6.7 kb) are shown, along with results from a 12 nt deletion experiment (5.8 kb plasmid) and an 18 nt insertion experiment (7.0 kb plasmid). In all three cases, over 90% of the resultant colonies had incorporated the desired mutation(s). Results are normalized to total transformants if cells were not diluted prior to plating. For comparison, the same substitution reaction (4 nt) was performed with the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent) following Agilent's protocol and using Agilent's primer design tool to design overlapping primers.

*Note that the QuikChange kit does not accommodate deletions and insertions of this size, so no comparison could be made for these experiments.

Kit Components

The following reagents are supplied with this product:

Store at (°C)

Concentration

Q5® Hot Start High-Fidelity 2X Master Mix

-20

2X

KLD Enzyme Mix

-20

10X

KLD Reaction Buffer

-20

2X

Control SDM Primer Mix

-20

10 μM

Control SDM Plasmid

-20

5 μg/ml

NEB® 5-alpha Competent E. coli (High Efficiency)

-80

pUC19 Vector

-20

0.05 ng/μl

SOC Outgrowth Medium

4


Related Products

Companion Products


Notes
  1. Storage Note:

    The Q5 Site-Directed Mutagenesis Kit is stable at -80°C for one year. For convenience, the Q5 Hot Start High-Fidelity 2X Master Mix, KLD Enzyme Mix, KLD Reaction Buffer, Control Primers and Template DNA are packaged together in a separate box that can be removed and stored at -20°C for two years with no loss of activity. The SOC can be removed and stored at room temperature. It is important to store the NEB 5-alpha Competent E. coli at -80°C, and avoid repeated freeze-thaw cycles.


Safety Data Sheet

The following is a list of Safety Data Sheet (SDS) that apply to this product to help you use it safely.









This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).

While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.

For more information about commercial rights, please contact NEB's Global Business Development team at gbd@neb.com.

This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

Licenses

This product is covered by one or more Patents.
This product is licensed from Bio-Rad Laboratories, Inc. under U.S. Pat. Nos. 6,627,424, 7,541,170, 7,670,808, 7,666,645 and corresponding patents in other countries for use only in: (a) standard (non-real time) PCR in the research field only, but not real time PCR or digital PCR; (b) any in vitro diagnostics application, except for applications using real time or digital PCR; and (c) any non-PCR applications in DNA sequencing, isothermal amplification and the production of synthetic DNA.

Trademarks

NEW ENGLAND BIOLABS® and Q5® are registered trademarks of New England Biolabs, Inc.
NEBASECHANGER is a trademark of New England Biolabs, Inc.

Disclaimers

  • This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.



ADDED